Inventor
ANAND NEEL K
US25 patents
⚠️ This page may combine multiple inventors who share the name “ANAND NEEL K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEKTAR THERAPEUTICS
18 patentsUS10434181B2Oct 8, 2019
Oligomer-containing benzamide-based compounds
NEKTAR THERAPEUTICS1 citations73
US9815824B2Nov 14, 2017
Kappa opioid agonists and uses thereof
NEKTAR THERAPEUTICS4 citations72
US11744898B2Sep 5, 2023
Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods
NEKTAR THERAPEUTICS2 citations71
US10322107B2Jun 18, 2019
N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor
NEKTAR THERAPEUTICS3 citations71
US10081602B2Sep 25, 2018
Opioid agonists and uses thereof
NEKTAR THERAPEUTICS2 citations71
US10189859B2Jan 29, 2019
Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine
NEKTAR THERAPEUTICS2 citations70
US9375486B2Jun 28, 2016
Oligomer-containing benzamide-based compounds
NEKTAR THERAPEUTICS1 citations63
US11111214B2Sep 7, 2021
Kappa opioid agonists and uses thereof
NEKTAR THERAPEUTICS0 citations62
US12214045B2Feb 4, 2025
Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods
NEKTAR THERAPEUTICS0 citations61
US11241415B2Feb 8, 2022
N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the κ opioid receptor
NEKTAR THERAPEUTICS0 citations61
US12325708B2Jun 10, 2025
Adenosine 2 receptor antagonists
NEKTAR THERAPEUTICS0 citations59
US12054553B2Aug 6, 2024
Immunotherapeutic tumor treatment method
NEKTAR THERAPEUTICS0 citations58
US12030940B2Jul 9, 2024
Immunotherapeutic tumor treatment method
NEKTAR THERAPEUTICS0 citations55
US9937266B2Apr 10, 2018
Oligomer-containing benzamide-based compounds
NEKTAR THERAPEUTICS0 citations52
US10407416B2Sep 10, 2019
Kappa opioid agonists and uses thereof
NEKTAR THERAPEUTICS0 citations51
US10865186B2Dec 15, 2020
Opioid agonists and uses thereof
NEKTAR THERAPEUTICS0 citations50
US10766864B2Sep 8, 2020
Morphinan derivatives for the treatment of neuropathic pain
NEKTAR THERAPEUTICS0 citations50
US10844076B2Nov 24, 2020
Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine
NEKTAR THERAPEUTICS0 citations49
SYMPHONY EVOLUTION INC
3 patentsUS10266518B2Apr 23, 2019
Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof
SYMPHONY EVOLUTION INC0 citations51
US9796704B2Oct 24, 2017
Substituted quinazolines as receptor-type kinase inhibitors
SYMPHONY EVOLUTION INC0 citations51
US9359332B2Jun 7, 2016
Processes for the preparation of substituted quinazolines
SYMPHONY EVOLUTION INC0 citations51